EGLN1 and melanoma: In melanoma cells treated with PHD2 inhibitor or in cells silenced for PHD2, ET-1 did not further increases HIF-1α or HIF-2α expression, angiogenesis and invasion, supporting that ET-1 regulates HIF-α-mediated effects through inhibition of PHD2.